Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
latest_posts
- 1
'Set up an Army Radio station at President’s Residence': Source close to Katz slams Herzog - 2Nations for Youngsters to Visit
- 3Help Your Efficiency: 10 Authoritative Apparatuses to Attempt
- 410 Activities to Lift Your Consume and Bust Your Stomach
- 5What causes RFK Jr.’s strained and shaky voice? A neurologist explains this little-known disorder
- Farmers call for French blockades over cow disease cull
- This Luxurious Thermal Spa In Italy Is Perfect For A Relaxing Escape While Visiting Milan
- A throat bone settles it - Nanotyrannus was not a juvenile T. rex
- 'The Golden Bachelor' Season 2 finale: How to watch tonight, start time, where to stream and more
- Find the Marvels of the World with These Travels
- Closets for Your Room: Plan and Utility Features
- Home Plan Tips for Seniors
- 5 Cell phones of the Year
- 2 ways you can conserve the water used to make your food
